Report Detail
Global Double Antibody Technology Platform Market Growth (Status and Outlook) 2022-2028
- RnM4497958 |
- 08 December, 2022 |
- Global |
- 111 Pages |
- LPI(LP Information) |
- Medical Industry
The global market for Double Antibody Technology Platform is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Double Antibody Technology Platform market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Double Antibody Technology Platform market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Double Antibody Technology Platform market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Double Antibody Technology Platform market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Double Antibody Technology Platform players cover Lindis Biotech, Roche, Amgen, AbbVie and WuXi Biologics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Double Antibody Technology Platform market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Double Antibody Technology Platform market, with both quantitative and qualitative data, to help readers understand how the Double Antibody Technology Platform market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Double Antibody Technology Platform market and forecasts the market size by Type (Full-length Double Antibody Technology Platform and Fragment Double Antibody Technology Platform,), by Application (Tumor, Autoimmune Disease, Infectious Diseases and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Full-length Double Antibody Technology Platform
Fragment Double Antibody Technology Platform
Segmentation by application
Tumor
Autoimmune Disease
Infectious Diseases
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Lindis Biotech
Roche
Amgen
AbbVie
WuXi Biologics
YZY Biopharma
Guangzhou Aisimai Biomedical Technology Co., Ltd.
GenScript Biotech
Sanofi
MacroGenics
Glenmark
Chugai
Abbott
Genmab
Affimed
EpimAb Biotherapeutics, Inc.
Alphamab Oncology
Chapter Introduction
Chapter 1: Scope of Double Antibody Technology Platform, Research Methodology, etc.
Chapter 2: Executive Summary, global Double Antibody Technology Platform market size and CAGR, Double Antibody Technology Platform market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Double Antibody Technology Platform revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Double Antibody Technology Platform revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Double Antibody Technology Platform market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Lindis Biotech, Roche, Amgen, AbbVie, WuXi Biologics, YZY Biopharma, Guangzhou Aisimai Biomedical Technology Co., Ltd., GenScript Biotech and Sanofi, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Double Antibody Technology Platform Market Size 2017-2028
- 2.1.2 Double Antibody Technology Platform Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Double Antibody Technology Platform Segment by Type
- 2.2.1 Full-length Double Antibody Technology Platform
- 2.2.2 Fragment Double Antibody Technology Platform
- 2.3 Double Antibody Technology Platform Market Size by Type
- 2.3.1 Double Antibody Technology Platform Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Double Antibody Technology Platform Market Size Market Share by Type (2017-2022)
- 2.4 Double Antibody Technology Platform Segment by Application
- 2.4.1 Tumor
- 2.4.2 Autoimmune Disease
- 2.4.3 Infectious Diseases
- 2.4.4 Other
- 2.5 Double Antibody Technology Platform Market Size by Application
- 2.5.1 Double Antibody Technology Platform Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Double Antibody Technology Platform Market Size Market Share by Application (2017-2022)
3 Double Antibody Technology Platform Market Size by Player
- 3.1 Double Antibody Technology Platform Market Size Market Share by Players
- 3.1.1 Global Double Antibody Technology Platform Revenue by Players (2020-2022)
- 3.1.2 Global Double Antibody Technology Platform Revenue Market Share by Players (2020-2022)
- 3.2 Global Double Antibody Technology Platform Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Double Antibody Technology Platform by Regions
- 4.1 Double Antibody Technology Platform Market Size by Regions (2017-2022)
- 4.2 Americas Double Antibody Technology Platform Market Size Growth (2017-2022)
- 4.3 APAC Double Antibody Technology Platform Market Size Growth (2017-2022)
- 4.4 Europe Double Antibody Technology Platform Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Double Antibody Technology Platform Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Double Antibody Technology Platform Market Size by Country (2017-2022)
- 5.2 Americas Double Antibody Technology Platform Market Size by Type (2017-2022)
- 5.3 Americas Double Antibody Technology Platform Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Double Antibody Technology Platform Market Size by Region (2017-2022)
- 6.2 APAC Double Antibody Technology Platform Market Size by Type (2017-2022)
- 6.3 APAC Double Antibody Technology Platform Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Double Antibody Technology Platform by Country (2017-2022)
- 7.2 Europe Double Antibody Technology Platform Market Size by Type (2017-2022)
- 7.3 Europe Double Antibody Technology Platform Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Double Antibody Technology Platform by Region (2017-2022)
- 8.2 Middle East & Africa Double Antibody Technology Platform Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Double Antibody Technology Platform Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Double Antibody Technology Platform Market Forecast
- 10.1 Global Double Antibody Technology Platform Forecast by Regions (2023-2028)
- 10.1.1 Global Double Antibody Technology Platform Forecast by Regions (2023-2028)
- 10.1.2 Americas Double Antibody Technology Platform Forecast
- 10.1.3 APAC Double Antibody Technology Platform Forecast
- 10.1.4 Europe Double Antibody Technology Platform Forecast
- 10.1.5 Middle East & Africa Double Antibody Technology Platform Forecast
- 10.2 Americas Double Antibody Technology Platform Forecast by Country (2023-2028)
- 10.2.1 United States Double Antibody Technology Platform Market Forecast
- 10.2.2 Canada Double Antibody Technology Platform Market Forecast
- 10.2.3 Mexico Double Antibody Technology Platform Market Forecast
- 10.2.4 Brazil Double Antibody Technology Platform Market Forecast
- 10.3 APAC Double Antibody Technology Platform Forecast by Region (2023-2028)
- 10.3.1 China Double Antibody Technology Platform Market Forecast
- 10.3.2 Japan Double Antibody Technology Platform Market Forecast
- 10.3.3 Korea Double Antibody Technology Platform Market Forecast
- 10.3.4 Southeast Asia Double Antibody Technology Platform Market Forecast
- 10.3.5 India Double Antibody Technology Platform Market Forecast
- 10.3.6 Australia Double Antibody Technology Platform Market Forecast
- 10.4 Europe Double Antibody Technology Platform Forecast by Country (2023-2028)
- 10.4.1 Germany Double Antibody Technology Platform Market Forecast
- 10.4.2 France Double Antibody Technology Platform Market Forecast
- 10.4.3 UK Double Antibody Technology Platform Market Forecast
- 10.4.4 Italy Double Antibody Technology Platform Market Forecast
- 10.4.5 Russia Double Antibody Technology Platform Market Forecast
- 10.5 Middle East & Africa Double Antibody Technology Platform Forecast by Region (2023-2028)
- 10.5.1 Egypt Double Antibody Technology Platform Market Forecast
- 10.5.2 South Africa Double Antibody Technology Platform Market Forecast
- 10.5.3 Israel Double Antibody Technology Platform Market Forecast
- 10.5.4 Turkey Double Antibody Technology Platform Market Forecast
- 10.5.5 GCC Countries Double Antibody Technology Platform Market Forecast
- 10.6 Global Double Antibody Technology Platform Forecast by Type (2023-2028)
- 10.7 Global Double Antibody Technology Platform Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Lindis Biotech
- 11.1.1 Lindis Biotech Company Information
- 11.1.2 Lindis Biotech Double Antibody Technology Platform Product Offered
- 11.1.3 Lindis Biotech Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Lindis Biotech Main Business Overview
- 11.1.5 Lindis Biotech Latest Developments
- 11.2 Roche
- 11.2.1 Roche Company Information
- 11.2.2 Roche Double Antibody Technology Platform Product Offered
- 11.2.3 Roche Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Roche Main Business Overview
- 11.2.5 Roche Latest Developments
- 11.3 Amgen
- 11.3.1 Amgen Company Information
- 11.3.2 Amgen Double Antibody Technology Platform Product Offered
- 11.3.3 Amgen Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Amgen Main Business Overview
- 11.3.5 Amgen Latest Developments
- 11.4 AbbVie
- 11.4.1 AbbVie Company Information
- 11.4.2 AbbVie Double Antibody Technology Platform Product Offered
- 11.4.3 AbbVie Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 AbbVie Main Business Overview
- 11.4.5 AbbVie Latest Developments
- 11.5 WuXi Biologics
- 11.5.1 WuXi Biologics Company Information
- 11.5.2 WuXi Biologics Double Antibody Technology Platform Product Offered
- 11.5.3 WuXi Biologics Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 WuXi Biologics Main Business Overview
- 11.5.5 WuXi Biologics Latest Developments
- 11.6 YZY Biopharma
- 11.6.1 YZY Biopharma Company Information
- 11.6.2 YZY Biopharma Double Antibody Technology Platform Product Offered
- 11.6.3 YZY Biopharma Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 YZY Biopharma Main Business Overview
- 11.6.5 YZY Biopharma Latest Developments
- 11.7 Guangzhou Aisimai Biomedical Technology Co., Ltd.
- 11.7.1 Guangzhou Aisimai Biomedical Technology Co., Ltd. Company Information
- 11.7.2 Guangzhou Aisimai Biomedical Technology Co., Ltd. Double Antibody Technology Platform Product Offered
- 11.7.3 Guangzhou Aisimai Biomedical Technology Co., Ltd. Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Guangzhou Aisimai Biomedical Technology Co., Ltd. Main Business Overview
- 11.7.5 Guangzhou Aisimai Biomedical Technology Co., Ltd. Latest Developments
- 11.8 GenScript Biotech
- 11.8.1 GenScript Biotech Company Information
- 11.8.2 GenScript Biotech Double Antibody Technology Platform Product Offered
- 11.8.3 GenScript Biotech Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 GenScript Biotech Main Business Overview
- 11.8.5 GenScript Biotech Latest Developments
- 11.9 Sanofi
- 11.9.1 Sanofi Company Information
- 11.9.2 Sanofi Double Antibody Technology Platform Product Offered
- 11.9.3 Sanofi Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Sanofi Main Business Overview
- 11.9.5 Sanofi Latest Developments
- 11.10 MacroGenics
- 11.10.1 MacroGenics Company Information
- 11.10.2 MacroGenics Double Antibody Technology Platform Product Offered
- 11.10.3 MacroGenics Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 MacroGenics Main Business Overview
- 11.10.5 MacroGenics Latest Developments
- 11.11 Glenmark
- 11.11.1 Glenmark Company Information
- 11.11.2 Glenmark Double Antibody Technology Platform Product Offered
- 11.11.3 Glenmark Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Glenmark Main Business Overview
- 11.11.5 Glenmark Latest Developments
- 11.12 Chugai
- 11.12.1 Chugai Company Information
- 11.12.2 Chugai Double Antibody Technology Platform Product Offered
- 11.12.3 Chugai Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Chugai Main Business Overview
- 11.12.5 Chugai Latest Developments
- 11.13 Abbott
- 11.13.1 Abbott Company Information
- 11.13.2 Abbott Double Antibody Technology Platform Product Offered
- 11.13.3 Abbott Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Abbott Main Business Overview
- 11.13.5 Abbott Latest Developments
- 11.14 Genmab
- 11.14.1 Genmab Company Information
- 11.14.2 Genmab Double Antibody Technology Platform Product Offered
- 11.14.3 Genmab Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Genmab Main Business Overview
- 11.14.5 Genmab Latest Developments
- 11.15 Affimed
- 11.15.1 Affimed Company Information
- 11.15.2 Affimed Double Antibody Technology Platform Product Offered
- 11.15.3 Affimed Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Affimed Main Business Overview
- 11.15.5 Affimed Latest Developments
- 11.16 EpimAb Biotherapeutics, Inc.
- 11.16.1 EpimAb Biotherapeutics, Inc. Company Information
- 11.16.2 EpimAb Biotherapeutics, Inc. Double Antibody Technology Platform Product Offered
- 11.16.3 EpimAb Biotherapeutics, Inc. Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 EpimAb Biotherapeutics, Inc. Main Business Overview
- 11.16.5 EpimAb Biotherapeutics, Inc. Latest Developments
- 11.17 Alphamab Oncology
- 11.17.1 Alphamab Oncology Company Information
- 11.17.2 Alphamab Oncology Double Antibody Technology Platform Product Offered
- 11.17.3 Alphamab Oncology Double Antibody Technology Platform Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 Alphamab Oncology Main Business Overview
- 11.17.5 Alphamab Oncology Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Double Antibody Technology Platform. Industry analysis & Market Report on Double Antibody Technology Platform is a syndicated market report, published as Global Double Antibody Technology Platform Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Double Antibody Technology Platform market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
